anti-GITR agonistic monoclonal antibody REGN6569

{
  "id": "MLC-T-ONC-010703",
  "term": "anti-GITR agonistic monoclonal antibody REGN6569",
  "field": "Oncology and biomedicine",
  "definition": "An agonistic monoclonal antibody targeting glucocorticoid-induced tumor necrosis factor receptor (GITR; tumor necrosis factor superfamily member 18; TNFRSF18; CD357), with potential immune checkpoint modulating and antineoplastic activities. Upon administration, anti-GITR agonistic monoclonal antibody REGN6569 targets, binds to and activates GITR, which is expressed on the cell surface of multiple types of T lymphocytes and other immune cells. This induces both the activation and proliferation of tumor antigen-specific T-effector cells (Teffs), and suppresses the function of activated T-regulatory cells (Tregs), which may promote the elimination of tumor cells. GITR, a member of the TNF receptor superfamily and T-cell receptor co-stimulator, is expressed on the surface of multiple immune cell types, including Tregs, Teffs, B-cells, and natural killer (NK) cells. Inappropriately activated Tregs suppress both Teffs and T-cell receptor (TCR) signaling.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/anti-gitr-agonistic-monoclonal-antibody-regn6569/"
}